869 related articles for article (PubMed ID: 13958)
1. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of beta-adrenoreceptors blockers.
Johnsson G; Regårdh CG
Drugs; 1976; 11 SUPPL 1():111-21. PubMed ID: 6243
[TBL] [Abstract][Full Text] [Related]
3. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
Säwe J
Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of prazosin.
Jaillon P
Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
Borchard U
Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of atenolol--a review.
Kirch W; Görg KG
Eur J Drug Metab Pharmacokinet; 1982; 7(2):81-91. PubMed ID: 6749509
[TBL] [Abstract][Full Text] [Related]
7. Cefetamet pivoxil clinical pharmacokinetics.
Blouin RA; Stoeckel K
Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic aspects of some beta-adrenoceptor blocking drugs.
Regårdh CG
Acta Med Scand Suppl; 1982; 665():49-60. PubMed ID: 6130675
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
Meier J
Am Heart J; 1982 Aug; 104(2 Pt 2):364-73. PubMed ID: 6125095
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of labetalol.
McNeil JJ; Louis WJ
Clin Pharmacokinet; 1984; 9(2):157-67. PubMed ID: 6370541
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of beta-receptor-blocking agents in relation to their anti-hypertensive effect.
Gugler R; Bodem G; Dengler HJ
Clin Sci Mol Med Suppl; 1976 Dec; 3():473s-475s. PubMed ID: 15758
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of anticonvulsants.
Hvidberg EF; Dam M
Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and renal function.
Wilkinson R
Drugs; 1982 Mar; 23(3):195-206. PubMed ID: 6122552
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
15. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Lemmer B; Winkler H; Ohm T; Fink M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of ketanserin.
Persson B; Heykants J; Hedner T
Clin Pharmacokinet; 1991 Apr; 20(4):263-79. PubMed ID: 2036747
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Shand DG
Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
[No Abstract] [Full Text] [Related]
18. Clinical pharmacokinetics of the salicylates.
Needs CJ; Brooks PM
Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of the antituberculosis drugs.
Holdiness MR
Clin Pharmacokinet; 1984; 9(6):511-44. PubMed ID: 6391781
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
Mehvar R; Brocks DR
J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
